Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cre-lox-regulated conditional RNA interference from transgenes.

Andrea Ventura1, Alexander Meissner, Christopher P Dillon

  • 1Department of Biology, Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

Proceedings of the National Academy of Sciences of the United States of America
|July 9, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Genomic Landscape of MYC, MYCL, and MYCN Amplified Solid Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

ZNF512B safeguards genome integrity at regulatory regions to repress the SASP and inflammation.

Cell stem cell·2026
Same author

Seeing is Believing: Intercellular Transfer of DNA between human cells.

Cancer research·2026
Same author

Dynamic optimization of extrachromosomal DNA copy number drives tumour evolution.

bioRxiv : the preprint server for biology·2026
Same author

Distinctive DNA sequence features define epigenetic longevity of inflammatory memory.

Science (New York, N.Y.)·2026
Same author

Evolution of oncogene amplification across 86,000 cancer cell genomes.

bioRxiv : the preprint server for biology·2026

Researchers developed novel lentiviral vectors for controlled RNA interference. These tools enable conditional activation or inactivation of short hairpin RNA (shRNA) expression, advancing genetic research in mammals.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biotechnology

Background:

  • RNA interference (RNAi) is a powerful tool for gene silencing.
  • Controlling RNAi spatially and temporally in vivo remains a challenge.
  • Existing methods lack precise regulation for functional genetic analysis.

Purpose of the Study:

  • To develop novel lentiviral vectors for conditional RNA interference.
  • To enable Cre-lox-regulated activation and inactivation of short hairpin RNA (shRNA) expression.
  • To facilitate precise spatial and temporal control of gene silencing in vivo.

Main Methods:

  • Generation of two lentiviral vectors: one for conditional activation, one for inactivation of shRNA.
  • Modification of the mouse U6 promoter with a LoxP site-TATA box hybrid for Cre-lox regulation.

Related Experiment Videos

  • Cell-based experiments to validate knockdown of p53, nucleophosmin, and DNA methyltransferase 1.
  • In vivo validation in Cre-expressing transgenic mice for tissue-specific RNA interference.

    • Main Results:

    • Demonstrated efficient and controllable shRNA expression in cell-based assays.
    • Successfully achieved conditional, tissue-specific RNA interference in transgenic mice.
    • Validated the vectors' ability to knock down target genes like p53, NPM1, and DNMT1.
    • Showcased spatial and temporal control of gene silencing in vivo.

    Conclusions:

    • The developed lentiviral vectors provide robust spatial and temporal control over shRNA expression.
    • These vectors are valuable tools for functional genetic analysis in mammals.
    • The Cre-lox-regulated system enhances the precision of RNA interference studies in vivo.